261 related articles for article (PubMed ID: 15757804)
21. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors.
Kojiro M; Nakashima O
Semin Liver Dis; 1999; 19(3):287-96. PubMed ID: 10518308
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
[TBL] [Abstract][Full Text] [Related]
23. Morphological changes of early human hepatocarcinogenesis.
Hytiroglou P
Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Zimmerman RL; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
26. [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma].
Nakashima O; Kojiro M
Gan To Kagaku Ryoho; 1996 Jun; 23(7):827-34. PubMed ID: 8678529
[TBL] [Abstract][Full Text] [Related]
27. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
[TBL] [Abstract][Full Text] [Related]
28. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases.
Song JS; Lee YJ; Kim KW; Huh J; Jang SJ; Yu E
Pathol Int; 2008 Aug; 58(8):503-12. PubMed ID: 18705771
[TBL] [Abstract][Full Text] [Related]
29. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
Kudo M
Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
[TBL] [Abstract][Full Text] [Related]
30. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
31. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
Roskams T
Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
[TBL] [Abstract][Full Text] [Related]
32. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
[TBL] [Abstract][Full Text] [Related]
33. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver.
Harada K; Terada T; Nakanuma Y; Furukawa Y; Kurumaya H
Am J Gastroenterol; 1993 Nov; 88(11):1968-9. PubMed ID: 8237956
[No Abstract] [Full Text] [Related]
34. Pathology of early hepatocellular carcinoma: progression from early to advanced.
Kojiro M; Yano H; Nakashima O
Semin Surg Oncol; 1996; 12(3):197-203. PubMed ID: 8727611
[TBL] [Abstract][Full Text] [Related]
35. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
[TBL] [Abstract][Full Text] [Related]
36. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
37. [Isolated tumor cells in primary malignant liver tumors].
Tannapfel A; Geissler F; Witzigmann H; Wittekind C
Zentralbl Chir; 2000; 125(7):602-5. PubMed ID: 10960969
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
40. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
